Influenza virus A infection of human monocyte and macrophage subpopulations reveals increased susceptibility associated with cell differentiation

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Hoeve, Marieke A ^a   Nash, Anthony A ^b   Jackson, David ^c   Randall, Richard E ^c   Dransfield, Ian ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CD14 ANTIGEN; CD16 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NONSTRUCTURAL PROTEIN 1; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS HEMAGGLUTININ;

APOPTOSIS; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL SUBPOPULATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLUENZA A; INFLUENZA VIRUS A; MACROPHAGE; MONOCYTE; MORBIDITY; MORTALITY; PHENOTYPE; VIRAL CLEARANCE; VIRUS CELL INTERACTION; ANIMAL; BLOOD; CELL CULTURE; CELL PHAGOCYTOSIS; CLASSIFICATION; DISEASE PREDISPOSITION; DOG; IMMUNOLOGY; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A H3N2; METABOLISM; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

HUMAN INFLUENZA VIRUS; INFLUENZAVIRUS A; ORTHOMYXOVIRIDAE;

ANIMALS; APOPTOSIS; CASPASES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; CYTOPHAGOCYTOSIS; DISEASE SUSCEPTIBILITY; DOGS; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MACROPHAGES; MONOCYTES;

EID: 84855388904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029443     Document Type: Article

References (72)

1. Horimoto T, Kawaoka Y, (2005) Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3: 591-600.
2. Palese P, (2004) Influenza: old and new threats. Nat Med 10: S82-87.
3. Thompson WW, Comanor L, Shay DK, (2006) Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis 194 (Suppl 2): S82-91.
4. Hayden F, (2009) Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis 48 (Suppl 1): S3-13.
5. McGill J, Heusel JW, Legge KL, (2009) Innate immune control and regulation of influenza virus infections. J Leukoc Biol 86: 803-812.
6. Ettensohn DB, Roberts NJ Jr, (1984) Influenza virus infection of human alveolar and blood-derived macrophages: differences in accessory cell function and interferon production. J Infect Dis 149: 942-949.
7. Jennings ST, Ettensohn DB, Roberts NJ Jr, (1984) Influenza virus infection of human alveolar and peripheral blood-derived macrophages. Production of factors that alter fibroblast proliferation. Am Rev Respir Dis 130: 98-102.
8. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6: 135.
9. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N, (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156: 1951-1959.
10. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM, (2008) H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 4: e1000115.
11. Taubenberger JK, Morens DM, (2008) The pathology of influenza virus infections. Annu Rev Pathol 3: 499-522.
12. Lin KL, Suzuki Y, Nakano H, Ramsburg E, Gunn MD, (2008) CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 180: 2562-2572.
13. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360: 1831-1837.
14. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, et al. (2008) A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 9: 1074-1083.
15. Sun K, Torres L, Metzger DW, (2010) A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol 84: 5007-5014.
16. Fesq H, Bacher M, Nain M, Gemsa D, (1994) Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology 190: 175-182.
17. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, et al. (1993) Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol 74 (Pt 11): 2347-2355.
18. Herold S, Steinmueller M, von Wulffen W, Cakarova L, Pinto R, et al. (2008) Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205: 3065-3077.
19. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, et al. (1995) In vivo induction of apoptosis by influenza virus. J Gen Virol 76 (Pt 11): 2869-2873.
20. Fujimoto I, Pan J, Takizawa T, Nakanishi Y, (2000) Virus clearance through apoptosis-dependent phagocytosis of influenza A virus-infected cells by macrophages. J Virol 74: 3399-3403.
21. Turpin E, Luke K, Jones J, Tumpey T, Konan K, et al. (2005) Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol 79: 8802-8811.
22. Savill J, Dransfield I, Gregory C, Haslett C, (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965-975.
23. Torchinsky MB, Garaude J, Martin AP, Blander JM, (2009) Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458: 78-82.
24. Di Paolo NC, Miao EA, Iwakura Y, Murali-Krishna K, Aderem A, et al. (2009) Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 31: 110-121.
25. Haskill S, Johnson C, Eierman D, Becker S, Warren K, (1988) Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. J Immunol 140: 1690-1694.
26. Franz S, Hoeve MA, Wickert S, Janko C, Dransfield I, (2009) Clearance of apo Nph induces an immunosuppressive response in pro-inflammatory type-1 and anti-inflammatory type-2 MPhi. Autoimmunity 42: 275-277.
27. Takizawa T, Tatematsu C, Ohashi K, Nakanishi Y, (1999) Recruitment of apoptotic cysteine proteases (caspases) in influenza virus-induced cell death. Microbiol Immunol 43: 245-252.
28. Wurzer WJ, Planz O, Ehrhardt C, Giner M, Silberzahn T, et al. (2003) Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 22: 2717-2728.
29. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, et al. (2004) Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 101: 4560-4565.
30. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
31. Passlick B, Flieger D, Ziegler-Heitbrock HW, (1989) Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74: 2527-2534.
32. Ziegler-Heitbrock HW, Fingerle G, Strobel M, Schraut W, Stelter F, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 23: 2053-2058.
33. Ziegler-Heitbrock HW, Passlick B, Flieger D, (1988) The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 7: 521-527.
34. Cros J, Cagnard N, Woollard K, Patey N, Zhang SY, et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33: 375-386.
35. Ziegler-Heitbrock L, (2007) The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
36. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116: e74-80.
37. Serbina NV, Cherny M, Shi C, Bleau SA, Collins NH, et al. (2009) Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia. J Immunol 183: 2678-2687.
38. Skrzeczynska-Moncznik J, Bzowska M, Loseke S, Grage-Griebenow E, Zembala M, et al. (2008) Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol 67: 152-159.
39. Pauligk C, Nain M, Reiling N, Gemsa D, Kaufmann A, (2004) CD14 is required for influenza A virus-induced cytokine and chemokine production. Immunobiology 209: 3-10.
40. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, et al. (1987) The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem 262: 1596-1601.
41. Li Y, Cao H, Dao N, Luo Z, Yu H, et al. (2011) High-throughput neuraminidase substrate specificity study of human and avian influenza A viruses. Virology 415: 12-19.
42. Bender A, Amann U, Jager R, Nain M, Gemsa D, (1993) Effect of granulocyte/macrophage colony-stimulating factor on human monocytes infected with influenza A virus. Enhancement of virus replication, cytokine release, and cytotoxicity. J Immunol 151: 5416-5424.
43. Stamatos NM, Liang F, Nan X, Landry K, Cross AS, et al. (2005) Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. FEBS J 272: 2545-2556.
44. Goerdt S, Orfanos CE, (1999) Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142.
45. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
46. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, et al. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686.
47. Martinez FO, Gordon S, Locati M, Mantovani A, (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177: 7303-7311.
48. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
49. Turchiarelli V, Schinkel J, Molenkamp R, Foschino Barbaro MP, Carpagnano GE, et al. (2011) Repeated virus identification in the airways of patients with mild and severe asthma during prospective follow-up. Allergy 66: 1099-1106.
50. Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal Malefyt R, et al. (2006) Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 36: 661-670.
51. Matikainen S, Pirhonen J, Miettinen M, Lehtonen A, Govenius-Vintola C, et al. (2000) Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 276: 138-147.
52. Nain M, Hinder F, Gong JH, Schmidt A, Bender A, et al. (1990) Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol 145: 1921-1928.
53. Wu W, Booth JL, Duggan ES, Wu S, Patel KB, et al. (2010) Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology 396: 178-188.
54. Chen Z, Li Y, Krug RM, (1999) Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J 18: 2273-2283.
55. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM, (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs. Mol Cell 1: 991-1000.
56. Hale BG, Randall RE, Ortin J, Jackson D, (2008) The multifunctional NS1 protein of influenza A viruses. J Gen Virol 89: 2359-2376.
57. Geiss GK, Salvatore M, Tumpey TM, Carter VS, Wang X, et al. (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A 99: 10736-10741.
58. Hayman A, Comely S, Lackenby A, Murphy S, McCauley J, et al. (2006) Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 347: 52-64.
59. Kim MJ, Latham AG, Krug RM, (2002) Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 99: 10096-10101.
60. Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, et al. (2011) Influenza Virus Infection Induces IL-33 in Mouse Lungs. Am J Respir Cell Mol Biol.
61. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, et al. (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12: 631-638.
62. Jackson D, Killip MJ, Galloway CS, Russell RJ, Randall RE, (2010) Loss of function of the influenza A virus NS1 protein promotes apoptosis but this is not due to a failure to activate phosphatidylinositol 3-kinase (PI3K). Virology 396: 94-105.
63. Hashimoto Y, Moki T, Takizawa T, Shiratsuchi A, Nakanishi Y, (2007) Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice. J Immunol 178: 2448-2457.
64. Giles KM, Hart SP, Haslett C, Rossi AG, Dransfield I, (2000) An appetite for apoptotic cells? Controversies and challenges. Br J Haematol 109: 1-12.
65. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE, (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 103: 14194-14199.
66. Leverrier Y, Okkenhaug K, Sawyer C, Bilancio A, Vanhaesebroeck B, et al. (2003) Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages. J Biol Chem 278: 38437-38442.
67. McColl A, Bournazos S, Franz S, Perretti M, Morgan BP, et al. (2009) Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J Immunol 183: 2167-2175.
68. Hart SP, Ross JA, Ross K, Haslett C, Dransfield I, (2000) Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ 7: 493-503.
69. Jersmann HP, Dransfield I, Hart SP, (2003) Fetuin/alpha2-HS glycoprotein enhances phagocytosis of apoptotic cells and macropinocytosis by human macrophages. Clin Sci (Lond) 105: 273-278.
70. Watanabe Y, Shiratsuchi A, Shimizu K, Takizawa T, Nakanishi Y, (2004) Stimulation of phagocytosis of influenza virus-infected cells through surface desialylation of macrophages by viral neuraminidase. Microbiol Immunol 48: 875-881.
71. Watanabe Y, Hashimoto Y, Shiratsuchi A, Takizawa T, Nakanishi Y, (2005) Augmentation of fatality of influenza in mice by inhibition of phagocytosis. Biochem Biophys Res Commun 337: 881-886.
72. Jersmann HP, Ross KA, Vivers S, Brown SB, Haslett C, et al. (2003) Phagocytosis of apoptotic cells by human macrophages: analysis by multiparameter flow cytometry. Cytometry A 51: 7-15.